PortfolioAxel Franz

Person data

Academic title:

PD Dr.

Name:

Axel Franz

Organizational unit:

University Children’s Hospital - Department of Paediatrics

Hospitals and clinical institutes

Contact data

Patents

Prophylaxe und Behandlung von frühgeburtlichkeitsassoziierten Entwicklungsstörungen

29/01/2015

Wolfgang Bernhard, Axel Franz

Projects

FAR-RMS – FRONTLINE AND RELAPSED RHABDOMYOSARCOMA: FAR-RMS clinical trial. EudraCT Nr. 2018-000515-24; ClinicalTrials.gov Identifier: NCT04625907

2024 - 2029

Axel Franz, Martin Ebinger, Monika Sparber-Sauer

Deutsche Forschungsgemeinschaft e.V. (DFG)

Kinder CTU BW – Kinder Clinical Trials Unit der Universitätsmedizin Baden-Württemberg

2024 - 2025

Ines Beatrice Brecht

Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (MWK)

NeoUp2 – E-health-supported assessment of psychological and somaticabnormalities, risk and resilience factors of premature infants and individualized, interdisciplinary and multimodal stepped-care care.

2023 - 2025

Annette Conzelmann, Tobias Renner, Johanna Löchner, Vanessa Nieratschker

Bili-PrediX1 – Assessment of neonatal hyperbilirubinemia by PrediX B.1 Algorithm- prospective observational study

2021 - 2022

Corinna Engel

NeoPrediX GmbH

CLAC5 – Klinische Langzeitevaluation eines automatischen Sauerstoffreglers für beatmete und atemunterstützte Frühgeborene - 5. Evaluationsstufe

2021 - 2022

Axel Franz

Heinen + Löwenstein GmbH & Co. KG

AsphysDx – Translation klinischer Marker für Sauerstoffmangel bei Neugeborenen in ein neues Diagnostikum zur Vermeidung frühkindlicher Hirnschäden und Steuerung einer individualisierten Therapie

2020 - 2022

Axel Franz

Land Baden-Württemberg

AAMBI2 – Asphyxia Associated Metabolite BiomarkerInvestigation 2

2019 - 2020

Corinna Engel, Axel Franz

InfanDx AG

Biomarkers And Neurological Outcome in Neonates 2

2019 - 2021

Corinna Engel, Axel Franz

InfanDx AG

firefleye – A randomized, 2-arm, open-label, phase 3 study to evaluate the efficacy, safety, and tolerability of intravitreal aflibercept versus laser photocoagulation in subjects with retinopathy of prematurity

2019 - 2020

Daniela Süsskind

Bayer AG

firefleye next – An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090

2019 - 2025

Daniela Süsskind

Bayer AG

c4c – Collaborative Network for European Clinical Trials for Children

2018 - 2024

Corinna Engel, Axel Franz

Robert Bosch Gesellschaft für medizinische Forschung mbH (RBMF)

YPAG Tübingen – Young People Advisory Group Tübingen

2018 - 2023

Axel Franz

Hilfe für kranke Kinder e.V.

ALBINO – Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic BrainInjury on Neurocognitive Outcme – a blinded randomized placebo-controlledmulticenter trial

2016 - 2020

Axel Franz

Europäische Union (EU)

FiO2-C – Effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcome of extremely preterm infants- a randomized controlled parallel group multicenter trial for safety and efficacy

2016 - 2022

Axel Franz

Bundesministerium für Bildung und Forschung (BMBF)

Forschungs-Information Tübingen (FIT)

PortfolioAxel Franz

Person data

Contact data

Patents

Projects

Publications